Dr. Ryan M. Dunn, M.D.
Pulmonology (Pulmonary Disease Physician)
- Medicare participating
At a glance
- Medical school
- University of Minnesota Medical School (2009)
- Years since graduation
- 17
- In the NPI registry since
- 2010
- Medicare patients seen, 2024
- 1,024
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2009Medical school: University of Minnesota Medical School
- 2010Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
FL license ME1258668
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Sarasota Memorial Hospital Sarasota, FL
- Sarasota Memorial Hospital - Venice North Venice, FL
- Lakewood Ranch Medical Center Bradenton, FL
- HCA Florida Sarasota Doctors Hospital Sarasota, FL
Medical groups
- Legacy Healthcare Services Inc (3,223 clinicians)
- Intercoastal Medical Group Inc (177 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 1,024
- Services billed
- 3,818
- Patients’ average age
- 77
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 661 | 322 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 657 | 269 |
| Critical care, first 30-74 minutes | 527 | 207 |
| Test to examine how well the lungs exchange gases | 254 | 242 |
| Test to determine lung volumes using gas dilution or washout | 251 | 240 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 236 | 226 |
| New patient office or other outpatient visit, 45-59 minutes | 232 | 232 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 141 | 133 |
| Insertion of needle into vein for collection of blood sample | 77 | 68 |
| Established patient office or other outpatient visit, 40-54 minutes | 57 | 37 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Sarasota, FL | 540 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Sarasota, FL | 259 |
| Prednisone Other prescribers in Sarasota, FL | 244 |
| Azithromycin Other prescribers in Sarasota, FL | 167 |
| Breo Ellipta (fluticasone/vilanterol) Other prescribers in Sarasota, FL | 118 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Sarasota, FL | 71 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Sarasota, FL | 59 |
| Doxycycline Hyclate Other prescribers in Sarasota, FL | 55 |
| Pantoprazole Sodium Other prescribers in Sarasota, FL | 34 |
| Montelukast Sodium Other prescribers in Sarasota, FL | 30 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 21 payments worth $543 in total to this clinician.
| AstraZeneca Pharmaceuticals LP | $324 |
|---|---|
| GlaxoSmithKline, LLC. | $66.39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $51.18 |
| Insmed, Inc. | $50.54 |
| United Therapeutics Corporation | $29.71 |
| Inogen, Inc. | $20.33 |
| Food and Beverage | $525 |
|---|---|
| Education | $17.38 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Insmed, Inc. Sep 11, 2025 | Education Brinsupri; Brinsupri · Respiratory · in-kind | $17.38 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $9,149 in research payments for these studies, mostly to the institutions running them.
- DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
United Therapeutics Corporation · Recruiting · NCT06388421
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.